GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HUTCHMED (China) Ltd (FRA:H7T2) » Definitions » 3-Month Share Buyback Ratio

HUTCHMED (China) (FRA:H7T2) 3-Month Share Buyback Ratio : 0.00% (As of Dec. 2024 )


View and export this data going back to 2018. Start your Free Trial

What is HUTCHMED (China) 3-Month Share Buyback Ratio?

3-Month Share Buyback Ratio only apply to companies whose reporting frequency is 3 months.


HUTCHMED (China) Business Description

Address
2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.